Online Vendors Selling Misbranded Weight-Loss Drugs

Published on February 14, 2024

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to two online vendors for selling unapproved and misbranded versions of semaglutide and tirzepatide, the active ingredients in popular diabetes and weight-loss drugs. The letters were issued…

Read Full Article (External Site)